We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+10.69%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.63B
AUM Growth
+$354M
Cap. Flow
+$42.2M
Cap. Flow %
0.91%
Top 10 Hldgs %
6.93%
Holding
1,360
New
97
Increased
499
Reduced
329
Closed
106

Top Buys

Rank Stock Value
1
PHIN icon
Phinia Inc
PHIN
+$19.2M
2
TGNA
TEGNA Inc
TGNA
+$16.8M
3
KSS icon
Kohl's
KSS
+$15M
4
CENTA icon
Central Garden & Pet Co Class A
CENTA
+$14.5M
5
ADNT icon
Adient
ADNT
+$12.1M

Sector Composition

Rank Sector Weight
1 Financials 27.28%
2 Consumer Discretionary 14%
3 Industrials 12.72%
4 Technology 9.9%
5 Healthcare 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LSBK icon
1051
Lake Shore Bancorp
LSBK
$134M
$213K ﹤0.01%
15,794
-13,056
-45% -$166K
LOGC
1052
DELISTED
ContextLogic
LOGC
$211K ﹤0.01%
38,700
EVER icon
1053
EverQuote
EVER
$906M
$211K ﹤0.01%
10,000
-6,500
-39% -$149K
ANTX icon
1054
AN2 Therapeutics
ANTX
$214M
$211K ﹤0.01%
197,000
+92,708
+89% +$161K
BRID icon
1055
Bridgford Foods
BRID
$56.5M
$210K ﹤0.01%
23,100
IOBT
1056
DELISTED
IO Biotech
IOBT
$210K ﹤0.01%
199,623
+75,000
+60% +$94.4K
PMVP icon
1057
PMV Pharmaceuticals
PMVP
$63.5M
$208K ﹤0.01%
139,900
SGMA
1058
DELISTED
Sigmatron International
SGMA
$207K ﹤0.01%
72,800
GOCO
1059
DELISTED
GoHealth
GOCO
$207K ﹤0.01%
22,048
+1,072
+5% +$10.9K
BLFY
1060
DELISTED
Blue Foundry Bancorp
BLFY
$205K ﹤0.01%
20,000
SUNS
1061
Sunrise Realty Trust
SUNS
$105M
$204K ﹤0.01%
+14,166
New +$182K
ENZ
1062
DELISTED
Enzo Biochem, Inc.
ENZ
$202K ﹤0.01%
180,800
+48,700
+37% +$54.5K
BCAB icon
1063
BioAtla
BCAB
$5.74M
$202K ﹤0.01%
2,300
+500
+28% +$41.9K
NRDY icon
1064
Nerdy
NRDY
$96.7M
$202K ﹤0.01%
+205,000
New +$263K
FNLC icon
1065
First Bancorp
FNLC
$399M
$200K ﹤0.01%
+7,612
New +$199K
SFIX
1066
Stitch Fix
SFIX
$560M
$200K ﹤0.01%
71,000
-97,500
-58% -$380K
MGX icon
1067
Metagenomi Therapeutics
MGX
$46.3M
$200K ﹤0.01%
+92,200
New +$320K
IVAC
1068
DELISTED
Intevac Inc
IVAC
$200K ﹤0.01%
58,800
+5,900
+11% +$21.5K
KPTI icon
1069
Karyopharm Therapeutics
KPTI
$48M
$199K ﹤0.01%
15,967
-1,666
-9% -$20.7K
XTNT icon
1070
Xtant Medical Holdings
XTNT
$62.3M
$198K ﹤0.01%
293,500
LOOP icon
1071
Loop Industries
LOOP
$32.9M
$198K ﹤0.01%
107,800
EAF icon
1072
GrafTech
EAF
$212M
$198K ﹤0.01%
+15,000
New +$125K
FLNT
1073
Fluent
FLNT
$120M
$197K ﹤0.01%
53,767
CNTY icon
1074
Century Casinos
CNTY
$34M
$194K ﹤0.01%
75,727
+3,752
+5% +$9.22K
NATR icon
1075
Nature's Sunshine
NATR
$288M
$192K ﹤0.01%
14,114
+268
+2% +$3.84K

Similar funds

Bridgeway Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Bridgeway Capital Management held 1,360 positions worth $4.63B, up 8.3% from $4.27B the previous quarter. Its ten largest holdings account for 6.9% of the portfolio.

Bridgeway Capital Management's Q3 2024 filing shows 97 new, 499 increased, 329 reduced and 106 closed positions. Its largest new stake was Phinia Inc: 427,196 shares worth $19.7M. The largest sale was Abercrombie & Fitch, an estimated $11M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q3 2024 buy was Phinia Inc: 427,196 shares worth $19.7M.
  • Bridgeway Capital Management added most to Central Garden & Pet Co Class A in Q3 2024, an estimated $14.5M increase.
  • Bridgeway Capital Management's biggest Q3 2024 reduction was Abercrombie & Fitch, cutting an estimated $11M.
  • Bridgeway Capital Management fully exited CleanSpark in Q3 2024, selling an estimated $7.03M.
  • Bridgeway Capital Management's ten largest holdings make up 6.9% of its $4.63B portfolio in Q3 2024.
  • Bridgeway Capital Management opened 97 new positions and closed 106 in Q3 2024.
  • Bridgeway Capital Management's portfolio value rose 8.3% quarter-over-quarter to $4.63B.

Based on Bridgeway Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.